BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25445421)

  • 1. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
    Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
    Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy.
    Mahendran A; Wong XL; Kao S; Sebaratnam DF
    Photodermatol Photoimmunol Photomed; 2019 May; 35(3):190-192. PubMed ID: 30554437
    [No Abstract]   [Full Text] [Related]  

  • 3. Images in clinical medicine. Cetuximab-associated acneiform eruption.
    Moss JE; Burtness B
    N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.
    Parma J; Pavlick A; Schiff R; Osborne CK; Chang JC; Rimawi M; Trivedi MV
    Pharmacotherapy; 2013 Oct; 33(10):1126-9. PubMed ID: 23744830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cutaneous effects of neratinib.
    Hamid RN; Ahn CS; Huang WW
    J Dermatolog Treat; 2019 Aug; 30(5):487-488. PubMed ID: 30321080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer.
    Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP
    J Dermatolog Treat; 2016; 27(2):148-52. PubMed ID: 26313697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 9. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Requena C; Llombart B; Sanmartín O
    Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
    Hsiao YW; Lin YC; Hui RC; Yang CH
    J Clin Oncol; 2011 Apr; 29(12):e340-1. PubMed ID: 21263088
    [No Abstract]   [Full Text] [Related]  

  • 11. Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.
    Anforth R; Liu M; Nguyen B; Uribe P; Kefford R; Clements A; Long GV; Fernandez-Peñas P
    Australas J Dermatol; 2014 Nov; 55(4):250-4. PubMed ID: 24313958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
    Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
    Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
    Beshay A; Petersen M; Rhoads JLW
    Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC(®) ) in the treatment of EGFR inhibitors-associated acneiform eruption.
    Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1436-8. PubMed ID: 26290481
    [No Abstract]   [Full Text] [Related]  

  • 15. Acneiform eruption due to vitamin B12: a problem still unsolved.
    Bettoli V; Zauli S; Montis A; Ruina G; Virgili A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):153-5. PubMed ID: 24566579
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of Dermatologic Complications of Lung Cancer Therapies.
    Pugliese SB; Neal JW; Kwong BY
    Curr Treat Options Oncol; 2015 Oct; 16(10):50. PubMed ID: 26338208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Shin JU; Park JH; Cho BC; Lee JH
    Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acneiform eruptions induced by cetuximab].
    Walon L; Gilbeau C; Lachapelle JM
    Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidermal growth factor receptor inhibitors side effects].
    Guhl G; González-de Arriba A; Daudén E
    Actas Dermosifiliogr; 2006 Jun; 97(5):296-310. PubMed ID: 16956561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ridaforolimus plus trastuzumab for patients with HER2+ trastuzumab-refractory metastatic breast cancer.
    Seiler M; Ray-Coquard I; Melichar B; Yardley DA; Wang RX; Dodion PF; Lee MA
    Clin Breast Cancer; 2015 Feb; 15(1):60-5. PubMed ID: 25239224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.